Diagnostics

Delivering a lateral flow diagnostic test to market is a huge challenge. By leveraging contract research organisations (CRO) with expertise in development we can accelerate your success. In this post, we explore the key moments…

Global Access Diagnostics (GADx) is thrilled to announce that we have been awarded the grand cash prize for our at-home urinary tract infection diagnostic by the National Institutes of Health’s (NIH) RADx Tech for Maternal…

GADx is pleased to announce its significant contribution to a groundbreaking study published in PLoS One. The research, titled “Performance of Novel Antibodies for Lipoarabinomannan to Develop Diagnostic Tests for Mycobacterium tuberculosis,” showcases the collaborative…

Global Access Diagnostics (GADx), a social enterprise prioritising equitable access to diagnostics and driving local manufacturing, today announced it has acquired the manufacturing rights for the IT LEISH rapid diagnostic test (RDT) for visceral leishmaniasis…

Global Access Health (GAH), a social enterprise dedicated to providing affordable medical products for global health, today formally introduced its first portfolio company, Global Access Diagnostics (GADx). GADx has been created to address gaps in…

Neglected Tropical Diseases affect more than one billion people worldwide, in some of the poorest areas. According to the World Health Organisation, schistosomiasis is a disease of poverty that leads to chronic ill health and…

Alamar Biosciences (Alamar), a platform company focused on transforming the field of proteomics to enable the early detection of cancer and other diseases, and Mologic, Ltd. (Mologic), part of the recently formed social enterprise Global…